Importance of beta-blocker therapy optimization in elderly patients with left ventricular systolic dysfunction

被引：0
|
作者：
Romero Daza, A. Angelica Maria [1 ]
Cortes Garcia, M. [1 ]
Franco, J. A. [1 ]
Palfy, J. A. [1 ]
De La Cruz, E. [1 ]
Avila, P. [1 ]
Martin, M. L. [1 ]
Briongos, S. [1 ]
Hernandez, I. [1 ]
Farre, J. A. [1 ]
机构：
[1] Fdn Jimenez Diaz, Cardiol, E-28040 Madrid, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1788
引用
收藏
页码：391 / 391
页数：1
相关论文
共 50 条
  • [21] IS THERE ANY BENEFIT WITH BETA BLOCKER THERAPY IN ASYMPTOMATIC LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: A META-ANALYSIS?
    Singh, Mukesh
    Shah, Tejaskumar
    Singh, Param
    Arora, Rohit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E297 - E297
  • [22] Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy
    Kajimoto, Hidemi
    Ishigaki, Keiko
    Okumura, Kenichi
    Tomimatsu, Hirofumi
    Nakazawa, Makoto
    Saito, Kayoko
    Osawa, Makiko
    Nakanishi, Toshio
    CIRCULATION JOURNAL, 2006, 70 (08) : 991 - 994
  • [23] Effect of beta-blocker therapy in elderly patients with dilated cardiomyopathy
    Hara, Y
    Hamada, M
    Shigematsu, Y
    Ohtsuka, T
    Ogimoto, A
    Suzuki, J
    Higaki, J
    CIRCULATION JOURNAL, 2003, 67 (10) : 826 - 829
  • [24] Diabetes is a predictor of effort tolerance and ventilatory efficiency in patients with moderate systolic dysfunction on beta-blocker therapy
    Pastormerlo, L. E.
    Emdin, M.
    Giannoni, A.
    Poletti, R.
    Fontana, M.
    Prontera, C.
    Passino, C.
    EUROPEAN HEART JOURNAL, 2010, 31 : 276 - 276
  • [25] Tolerability of beta-blocker therapy in the elderly heart failure patients
    Khalid, A
    Simbaqueba, C
    Powers, J
    Butler, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S158 - S158
  • [26] The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study
    Wen, Xue-Song
    Luo, Rui
    Liu, Jie
    Liu, Zhi-Qiang
    Zhang, Han-Wen
    Hu, Wei-Wei
    Duan, Qin
    Qin, Shu
    Xiao, Jun
    Zhang, Dong-Ying
    CLINICAL CARDIOLOGY, 2022, 45 (05) : 509 - 518
  • [27] Efficacy of ivabradine in combination with beta-blocker, compared with uptitration of beta-blocker, on systolic function and left ventricular remodeling in patients after Q-wave myocardial infarction
    Amosova, E.
    Prudky, I.
    Xu, Y.
    Bezrodnyi, A.
    Andrejev, E.
    EUROPEAN HEART JOURNAL, 2011, 32 : 340 - 340
  • [28] IS THE USE OF BETA-BLOCKER THERAPY DECREASED IN THE ELDERLY
    FORMAN, DE
    WEI, JY
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1991, 39 (08) : A49 - A49
  • [29] Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction
    Stanek, B
    Frey, B
    Hülsmann, M
    Berger, R
    Sturm, B
    Strametz-Juranek, J
    Bergler-Klein, J
    Moser, P
    Bojic, A
    Hartter, E
    Pacher, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) : 436 - 442
  • [30] Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction
    Al-Nasser, F
    Duncan, A
    Sharma, R
    O'Sullivan, C
    Coats, AJS
    Anker, SD
    Henein, MY
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 86 (2-3) : 199 - 205
12345